High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyL

<div>Test <sup>18</sup>F-DCFPyL PET/CT (a) compared to retest <sup>18</sup>F-DCFPyL PET/CT (b). A 88-year old patient afflicted with prostate cancer (Gleason Score 7) referring for staging (prostate-specific antigen level at time of scan, 69.55 ng/ml). Maximum intensity projections of both scans revealed an identical DCFPyL-avid lymph node in the skeleton, including the ribs and the pelvis (red arrows).</div>

Molecular Imaging

fig2

Figure 2

Figure 2: High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with <sup>18</sup>F-DCFPyL 

Figure 2 | High SUVs Have More Robust Repeatability in Patients with Metastatic Prostate Cancer: Results from a Prospective Test-Retest Cohort Imaged with 18F-DCFPyL 